PharmTech LCGC Sciex Webinar 11.10
|Articles|December 12, 2007

Researchers Assess Proteomics to Study COPD

Italian and American researchers have employed a new approach for studying the progression of chronic obstructive pulmonary disease (COPD).

Italian and American researchers have employed a new approach for studying the progression of chronic obstructive pulmonary disease (COPD). The researchers set out to study the suitability of proteomics methods to identify changes in protein expression that are related to the disease, according to spectroscopynow.com. The researchers analyzed sputum from people affected by COPD and compared the protein profiles to pick out potential biomarkers.

Proteins collected at the aqueous interface were digested with trypsin. All digests were analyzed by HPLC-tandem mass spectrometry with electrospray ionisation and the peptides were matched to proteins using standard MS/MS software.A total of 203 proteins were identified, 118 were detected for the first time. As anticipated, the researchers found that several proteins were detected more frequently in some groups of subjects than others. Closer examination is expected to provide a clearer understanding of COPD and to establish a panel of proteins as biomarkers for the different stages of the disease.


Related to this article

Best of the Week: From Cancer Diagnostics to Smarter LC Method Development
This week, Chromatography Online’s coverage spanned lipidomics-based early cancer detection, career paths in separation science, machine learning and uncertainty-driven approaches to LC method development, new EU wastewater rules for pharmaceutical micropollutants, automated Separation Quality Factor (SQF) evaluation in chromatography data systems, and solutions to GLP-1 peptide analysis challenges.